China Pharmaceuticals and Healthcare Report Q1 2015
Includes 3 FREE quarterly updates
NEW YORK, Dec. 24, 2014 /PRNewswire/ -- BMI View:
Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.
Headline Expenditure Projections
- Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7% in local currency and +16.1% in US dollar terms.
- Healthcare: CNY3,230.8bn (USD525.4bn) in 2013 to CNY3,733.1bn (USD609.2bn) in 2014; +15.6% in local currency terms and +15.9% in US dollar terms. Forecast has been upgraded from Q414 due to upgraded growth in private health expenditure.
Read the full report: http://www.reportlinker.com/p01931509-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-pharmaceuticals-and-healthcare-report-q1-2015-300013686.html
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article